Evidence mapPaperPMID 28627980Full record

Trial reportThe Journal of international medical research2017

Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death.

Anne Pernille Ofstad, Geir Reinvik Ulimoen, Elsa Orvik, Kåre Inge Birkeland, Lars L Gullestad, Morten Wang Fagerland, Odd Erik Johansen

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of international medical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00133718 (Asker and Baerum Cardiovascular Diabetes Study), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00133718 phase4completednot on this map

Asker and Baerum Cardiovascular Diabetes Study

TypeinterventionalSponsorAsker & Baerum HospitalRan2002 to 2012Enrolled120ConditionsType 2 Diabetes MellitusArmsCombined lifestyle intervention and optimisation of pharmacological treatment
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Anne Pernille Ofstad1 Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
Geir Reinvik Ulimoen2 Department of Radiology, Akershus University Hospital, Lørenskog, Norway.
Elsa Orvik1 Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
Kåre Inge Birkeland3 Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Lars L Gullestad4 Department of Cardiology, Oslo University Hospital, Oslo, Norway.
Morten Wang Fagerland5 Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
Odd Erik Johansen1 Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
Vestre Viken Hospital Trust · NOOslo University Hospital · NOAkershus University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective To report the long-term impact on cardiovascular (CV) outcomes and mortality of a 2-year hospital-based multi-interventional care programme as compared with general practitioner (GP)-provided standard care. Methods Patients with type 2 diabetes with ≥ 1 additional CV risk factor were randomized to 2 years of specialist-based, multi-intervention comprising lifestyle modification and specific pharmacological treatment, or GP-based standard care. After the 2-year intervention period, all participants returned to pre-study care, but were followed up for CV outcomes and mortality. The primary outcome was time to any first severe CV event or death. Results A total of 120 patients (31 women) were enrolled in the study. During the mean ± SD observational period of 8.7 ± 2.0 years, 27 patients (16 and 11 in the multi-intervention and standard care groups, respectively) experienced at least one primary outcome event, with a hazard ratio (HR) if allocated to the multi-intervention group of 1.73 (95% confidence interval (CI) 0.80, 3.75). The HR for total mortality was 1.82 (95% CI 0.66, 5.01). Conclusions Hospital-based multi-intervention in patients with type 2 diabetes mellitus improved long-term glycaemic control, but failed to reduce CV outcomes and deaths. Clinical trials.gov id: NCT00133718.

Indexed as

HospitalsAlbuminuriaCardiovascular DiseasesConfidence IntervalsDiabetes Mellitus, Type 2FemaleFollow-Up StudiesHumansLife StyleMaleTime Factorscardiovascular diseasecardiovascular eventsglitazonesmortalitymultifactorial treatmentType 2 diabetes mellitus

Identifiers

PMID28627980
PMCPMC5718720
OpenAlexW2627589249

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.